Is Oncopeptides AB (publ) (ONCO.ST) a Buy, Sell, or Hold?
STO : ONCO.ST
Oncopeptides AB (publ)
$1.57 SEK
-$0.01 (-0.76%)
- Volume
- 459.49K
- Average Volume
- 5.59M
- Market Capitalization
- $379.88M
- P/E Ratio
- -1.67
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $6.55
- Year Low
- $1.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.55
Company Overview
STO
Sofia Heigis
Biotechnology
Healthcare
ONCO.ST
75
SE
SEK
Liquidity Metrics
1.70
4.55
4.40
3.64
0.00
Sales & Valuation
$71.12M
4.56
5.48
-1.90
-0.75
Profitability
-$1.1
-$249.58M
-265.27%
-263.48%
2083.70%
-81.32%
P/E Metrics
-1.67
-0.04
-0.04
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-0.15
3/9
$200.04M
$271.89M
$195.11M
-$206.98M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| David Augustsson | Director of IR, Communications & Corporate Affairs |
| Henrik Bergentoft | Chief Financial Officer |
| Eva Nordström | Chief Operating Officer & Deputy MD |
| Sofia Heigis | Chief Executive Officer |
| Peter Nygren | Founder |
| Hans Ehrsson | Founder |
| Joachim Gullbo | Founder |
| Rolf Larsson | Founder |
| Rolf Lewensohn | Founder |
| Kristina Luthman | Founder |
Poll Results
No votes yet today — be the first to share your view!
About Oncopeptides AB (publ) (STO:ONCO.ST) Stock
Oncopeptides AB (publ) is a biotechnology firm dedicated to developing medical therapies for cancer, serving markets across the United States, Europe, and worldwide. Its foremost experimental compound, melflufen, is a distinct peptide-drug conjugate engineered to address multiple myeloma that has relapsed or become resistant to prior treatments in adult individuals. Founded in 2000, Oncopeptides AB (publ) conducts its main business from Stockholm, Sweden. ...
Frequently Asked Questions
-
What is the current Oncopeptides AB (publ) (ONCO.ST) stock price?
-
Oncopeptides AB (publ)(STO:ONCO.ST) stock price is $1.57 in the last trading session. During the trading session, ONCO.ST stock reached the peak price of $6.55 while $1.255 was the lowest point it dropped to. The percentage change in ONCO.ST stock occurred in the recent session was --0.76% while the dollar amount for the price change in ONCO.ST stock was -$0.01.
-
ONCO.ST's industry and sector of operation?
-
The STO listed ONCO.ST is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ONCO.ST?
-
David Augustsson | Director of IR, Communications & Corporate Affairs
Henrik Bergentoft | Chief Financial Officer
Eva Nordström | Chief Operating Officer & Deputy MD
Sofia Heigis | Chief Executive Officer
Peter Nygren | Founder -
How many employees does ONCO.ST have?
-
Number of ONCO.ST employees currently stands at 75. ONCO.ST operates from Luntmakargatan 46, Stockholm, AB 111 53, SE.
-
Link for ONCO.ST official website?
-
Official Website of ONCO.ST is: https://www.oncopeptides.com/sv
-
How do I contact ONCO.ST?
-
ONCO.ST could be contacted at phone #46 86 15 20 40 and can also be accessed through its website. ONCO.ST operates from Luntmakargatan 46, Stockholm, AB 111 53, SE.
-
How many shares of ONCO.ST are traded daily?
-
The average number of ONCO.ST shares traded daily for last 3 months was 5.59M.
-
What is the market cap of ONCO.ST currently?
-
The market value of ONCO.ST currently stands at $379.88M with its latest stock price at $1.57